| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/13/2006 | WO2006072888A2 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 07/13/2006 | WO2006072881A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 07/13/2006 | WO2006072832A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 07/13/2006 | WO2006072783A1 Sulfasalazine analogues as nf-kb inhibitors |
| 07/13/2006 | WO2006072639A1 Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events |
| 07/13/2006 | WO2006072354A1 Squaric acid derivatives |
| 07/13/2006 | WO2006072350A1 Cyanoguanidine-substituted pyrazolines |
| 07/13/2006 | WO2006072349A1 Thiophene-substituited pyrazolines |
| 07/13/2006 | WO2006029577A8 Methods and compositions for the treatment of hyperlipidemia |
| 07/13/2006 | WO2005110413A3 Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
| 07/13/2006 | US20060154982 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases such as cancer, psoriasis, arteriosclerosis or is at risk of restenosis of the coronary arteries after vascular surgery |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154936 Use of n-'5-'4-(4-methylpiperaziomethyl)-benzoylamido!-2-methylphenyl!-4-(3-pyridyl)2-pyridine-amine for the treatment of pulmonary hypertension |
| 07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |
| 07/13/2006 | US20060154912 Isophtalic acid derivatives |
| 07/13/2006 | US20060154907 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 07/13/2006 | US20060154884 Use of a vegf receptor gener or gene product |
| 07/13/2006 | US20060154876 Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 07/13/2006 | US20060154295 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 07/13/2006 | US20060153931 Prevention of flap necrosis in plastic surgery |
| 07/13/2006 | US20060153912 Choline ascorbate formulations |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153770 Method of treating tumors |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | CA2594433A1 Compositions comprising the 2s,4r ketoconazole enantiomer for treating diabetes, metabolic syndrome and other conditions |
| 07/13/2006 | CA2594404A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | CA2594388A1 Squaric acid derivatives |
| 07/13/2006 | CA2594363A1 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 07/13/2006 | CA2594233A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 07/13/2006 | CA2593768A1 Use of .omega.3 unsaturated fatty acids for relieving lipotoxicity |
| 07/13/2006 | CA2593432A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 07/13/2006 | CA2593098A1 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 07/13/2006 | CA2592771A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | CA2592007A1 Triazolophthalazines |
| 07/13/2006 | CA2585733A1 Adiponectin variants |
| 07/12/2006 | EP1679083A2 Use of metaloporphyrins for treatment of arteriosclerotic lesions |
| 07/12/2006 | EP1679079A1 Plant seed extract composition and process for producing the same |
| 07/12/2006 | EP1679073A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(imino-heterocyclyl)-phenyl-amide derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 07/12/2006 | EP1679070A1 Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |
| 07/12/2006 | EP1679068A1 Composition functioning to prevent or mitigate symptom or disease attributable to blood vessel aging |
| 07/12/2006 | EP1679067A1 Concurrent drugs |
| 07/12/2006 | EP1679058A1 Pharmaceutical composition for the treatment of angiocardiopathy |
| 07/12/2006 | EP1678499A2 Chemical compound and assay |
| 07/12/2006 | EP1677831A1 Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |
| 07/12/2006 | EP1677779A1 Novel association consisting of an anti-atherothrombotic agent and of a platelet antiaggregating agent |
| 07/12/2006 | EP1677597A2 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes |
| 07/12/2006 | EP1516866B1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 07/12/2006 | EP1467750B1 Orodispersible pharmaceutical composition comprising perindopril |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 07/12/2006 | EP1389212B1 3,7-diazabicyclo 3.3.1| formulations as anti-arrythmic compounds |
| 07/12/2006 | EP1338604B1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1222163B1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 07/12/2006 | EP1124950B1 Morpholino based p53 antisense oligonucleotide, and uses thereof |
| 07/12/2006 | EP0869808B1 Use of glu-trp dipeptides for the manufacture of a medicament for the treatment of different conditions involving neovascularization |
| 07/12/2006 | CN1802178A Solid formulation |
| 07/12/2006 | CN1800373A Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody |
| 07/12/2006 | CN1800207A Polypeptide for decreasing blood pressure, its separation method and uses |
| 07/12/2006 | CN1800206A Corn albumen powder polypeptide, its separation method and uses |
| 07/12/2006 | CN1800182A N2-arylformyl-4-ammonia/amidopteridine analog compound capable of regulating nitrous oxide synthase acitivity |
| 07/12/2006 | CN1800164A Kukoline C ring modified derivative and its synthesis method |
| 07/12/2006 | CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 07/12/2006 | CN1799629A Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
| 07/12/2006 | CN1799627A Natto kinase oral liquid and its manufacturing method |
| 07/12/2006 | CN1799605A 'Shengmai' infusion and its preparation process |
| 07/12/2006 | CN1799601A Blood lipid-lowering medicine and preparation method thereof |
| 07/12/2006 | CN1799596A Pharmaceutical composition for treating cerebral apoplexy and its preparation method |
| 07/12/2006 | CN1799594A Medicine for treating cardiovascular and cerebrovascular disease and its preparing process |
| 07/12/2006 | CN1799582A Blood sugar- and blood pressure-lowering medicine |
| 07/12/2006 | CN1799581A Moutan bark effective constituent and preparation method thereof |
| 07/12/2006 | CN1799580A Medicinal pills for promote blood circulation to dispel blood stasis and tonifying qi to stop pain and preparation method thereof |
| 07/12/2006 | CN1799577A Method for preparing Chinese proprietary formulation for treatment of coronary heart disease, angina pectoris and other cardiovascular diseases |
| 07/12/2006 | CN1799568A Preparation method of medicine for coronary heart disease treating angina pectoris and chest oppression feeling |
| 07/12/2006 | CN1799566A Pharmaceutical composition for preventing and treating cerebral ischemic reperfusion injury |
| 07/12/2006 | CN1799553A Thrombus dissolving tablet and preparation |
| 07/12/2006 | CN1799549A Process for preparing soybean isoflavone phospholipid composition |
| 07/12/2006 | CN1799543A Telmisartan dispersible tablet and its preparation method |
| 07/12/2006 | CN1799542A Hawthorn fruit total flavone phospholipid composition and its preparation method |
| 07/12/2006 | CN1263853C Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 07/12/2006 | CN1263852C Extracellular matrix signalling molecules |
| 07/12/2006 | CN1263842C New type health-care liquid from mashed onion and its preparation method |
| 07/12/2006 | CN1263758C 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
| 07/12/2006 | CN1263743C Therapeutic morpholino-substituted compounds |
| 07/12/2006 | CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses |
| 07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
| 07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 07/12/2006 | CN1263502C Chinese traditional medicine for treating hypertension |
| 07/12/2006 | CN1263491C Capsule for treating myocarditis of coxsackie B virus type, and its preparation method |
| 07/12/2006 | CN1263483C Medicinal capsule of rhubarb horsetails and granule beetle and its preparation method |
| 07/12/2006 | CN1263482C Externally-used Chinese medicine preparation for treating anal-intestinal disorder and its preparing method |
| 07/12/2006 | CN1263479C Chinese traditional medicine for treating cardiopathy |